Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation.
Lupus
; 26(7): 773-776, 2017 Jun.
Article
en En
| MEDLINE
| ID: mdl-27687020
ABSTRACT
Systemic lupus erythematosus (SLE), a disorder of the immune system, is potentially curable by allogeneic bone marrow transplantation (alloBMT). Until recently, alloBMT was limited by donor availability and toxicity. Reduced intensity conditioning (RIC) combined with post-transplantation cyclophosphamide (PTCy) has improved the availability and safety of alloBMT permitting its exploration in severe-refractory autoimmune illnesses. We report the six-year follow-up of a young female whose refractory SLE-associated nephrosis resolved after RIC alloBMT with PTCy.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Trasplante de Médula Ósea
/
Acondicionamiento Pretrasplante
/
Ciclofosfamida
/
Lupus Eritematoso Sistémico
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Lupus
Asunto de la revista:
REUMATOLOGIA
Año:
2017
Tipo del documento:
Article